אורורק 4 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

SILODOSIN 4 MG

MAH:

DOR PHARMACEUTICAL SERVICES, ISRAEL

ATC_code:

G04CA04

pharmaceutical_form:

HARD CAPSULE

administration_route:

PER OS

manufactured_by:

RECORDATI IRELAND LTD

therapeutic_group:

SILODOSIN

therapeutic_indication:

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

authorization_date:

2013-06-01